John Carstensen
Linkoeping, E 58183, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
Journal: Molecular and clinical oncology
Published: April 09, 2019
Development of a multiperspective optical measuring system for investigating decaying switching arcs at the nozzle exit of circuit breakers.
Journal: Applied optics
Published: March 02, 2017
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 13, 2017
Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
Journal: International journal of cancer
Published: November 08, 2015
Intergenerational Cohort Study of Preterm and Small-for-Gestational-Age Birth in Twins and Singletons.
Journal: Twin research and human genetics : the official journal of the International Society for Twin Studies
Published: September 03, 2015
Stage-specific direct health care costs in patients with cutaneous malignant melanoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: November 09, 2014
Experience of a serious life event increases the risk for childhood type 1 diabetes: the ABIS population-based prospective cohort study.
Journal: Diabetologia
Published: October 23, 2014
Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
Journal: The British journal of dermatology
Published: October 06, 2014
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 02, 2014
AEG-1 expression is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy: a study in a Swedish clinical trial.
Journal: British journal of cancer
Published: June 20, 2013
Last Updated: 09/26/2026